Abstract
Gastric cancer (GC) is the leading cause of death and cancer mortality in the world, with poor survival for cases with higher stages of GC. During the past decade, GC stem cells (GCSCs), a group of cancer cells, have been the focus of significant research on cancer. GCSCs have the capability of selfrenewal and are identified to participate in GC development, invasion, chemoresistance, and tumor relapse. Research projects have indicated the main activities of noncoding RNAs in cellular pathways. Micro (mi)RNAs and lncRNAs play important functions in the modulation of different cellular pathways in the post-transcriptional form through their dysregulated expression in several cancers, including GC. In this paper, we highlight the impact of dysregulated expression of micro- and lncRNAs and their downstream transcripts on GCSCs. Data collection on the progression of GCSCs may be beneficial for the introduction of new insights to the GC treatment.
Keywords: Gastric cancer, non-coding RNAs, stem cells, cancer treatment, miRNAs, lncRNAs.
Graphical Abstract
[1]
Dastmalchi N, Safaralizadeh R, Banan Khojasteh SM. The correlation between microRNAs and Helicobacter pylori in gastric cancer. Pathog Dis 2019; 77(4): ftz039.
[http://dx.doi.org/10.1093/femspd/ftz039] [PMID: 31351000]
[http://dx.doi.org/10.1093/femspd/ftz039] [PMID: 31351000]
[2]
Dastmalchi N, Khojasteh SMB, Nargesi MM, Safaralizadeh R. The correlation between lncRNAs and Helicobacter pylori in gastric cancer. Pathog Dis 2019; 77(9): ftaa004.
[http://dx.doi.org/10.1093/femspd/ftaa004] [PMID: 31981356]
[http://dx.doi.org/10.1093/femspd/ftaa004] [PMID: 31981356]
[3]
(a) Jafari N, Abediankenari S. MicroRNA-34 dysregulation in
gastric cancer and gastric cancer stem cell. Tumour Biol 2017; 39(5): 1010428317701652.
[http://dx.doi.org/10.1177/1010428317701652] [PMID: 28468587] ; (b) Pourmahdi M, Saber A, Rajabi A, Abdolahi S, Ebrahimi P, Safaralizadeh R. Key epigenetic events involved in the maintenance of breast cancer stem cells. Curr Stem Cell Res Ther 2021; 16(7): 877-87.
[http://dx.doi.org/10.2174/1574888X16666210203111605] [PMID: 33563177]
[http://dx.doi.org/10.1177/1010428317701652] [PMID: 28468587] ; (b) Pourmahdi M, Saber A, Rajabi A, Abdolahi S, Ebrahimi P, Safaralizadeh R. Key epigenetic events involved in the maintenance of breast cancer stem cells. Curr Stem Cell Res Ther 2021; 16(7): 877-87.
[http://dx.doi.org/10.2174/1574888X16666210203111605] [PMID: 33563177]
[4]
Khan AQ, Ahmed EI, Elareer NR, Junejo K, Steinhoff M, Uddin S. Role of miRNA-regulated cancer stem cells in the pathogenesis of hu-man malignancies. Cells 2019; 8(8): E840.
[http://dx.doi.org/10.3390/cells8080840] [PMID: 31530793]
[http://dx.doi.org/10.3390/cells8080840] [PMID: 31530793]
[5]
Moharil RB, Dive A, Khandekar S, Bodhade A. Cancer stem cells: An insight. J Oral Maxillofac Pathol 2017; 21(3): 463.
[http://dx.doi.org/10.4103/jomfp.JOMFP_132_16] [PMID: 29391738]
[http://dx.doi.org/10.4103/jomfp.JOMFP_132_16] [PMID: 29391738]
[6]
Courtois S, Durán RV, Giraud J, et al. Metformin targets gastric cancer stem cells. Eur J Cancer 2017; 84: 193-201.
[http://dx.doi.org/10.1016/j.ejca.2017.07.020] [PMID: 28822889]
[http://dx.doi.org/10.1016/j.ejca.2017.07.020] [PMID: 28822889]
[7]
Fu Y, Du P, Zhao J, Hu C, Qin Y, Huang G. Gastric cancer stem cells: Mechanisms and therapeutic approaches. Yonsei Med J 2018; 59(10): 1150-8.
[http://dx.doi.org/10.3349/ymj.2018.59.10.1150] [PMID: 30450848]
[http://dx.doi.org/10.3349/ymj.2018.59.10.1150] [PMID: 30450848]
[8]
Norollahi SE, Mansour-Ghanaei F, Joukar F, et al. Therapeutic approach of cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy. Biomed Pharmacother 2019; 115: 108958.
[9]
(a) Sun X, Jiao X, Pestell TG, et al. MicroRNAs and cancer stem
cells: the sword and the shield. Oncogene 2014; 33(42): 4967-77.
[http://dx.doi.org/10.1038/onc.2013.492] [PMID: 24240682] ; (b) Hui Y, Yang Y, Li D, et al. LncRNA FEZF1-AS1 modulates cancer stem cell properties of human gastric cancer through miR- 363-3p/HMGA2. Cell Transplant 2020; 29: 963689720925059.
[http://dx.doi.org/10.1177/0963689720925059] [PMID: 32638620] ; (c) Behzadi S, Baradaran B, Hosseinpourfeizi MA, et al. BC032913 as a novel antisense non-coding RNA is downregulated in gastric cancer. J Gastrointest Cancer 2021; 53(2): 928-31.
[PMID: 32914372] ; (d) Mohammadzadeh A, Baradaran B, Dastmalchi N, Hashemzadeh S, Safaralizadeh R. The correlation between helicobacter pylori infection and lnc-oc1 expression in gastric cancer tissues in an iranian population. J Gastrointest Cancer 2021; 52(2): 600-5.
[http://dx.doi.org/10.1007/s12029-020-00438-4] [PMID: 32529394] ; (e) Azarbarzin S, Safaralizadeh R, Khojasteh MB, Baghbanzadeh A, Baradaran B. Current perspectives on the dysregulated microRNAs in gastric cancer. Mol Biol Rep 2020; 47(9): 7253-64.
[http://dx.doi.org/10.1007/s11033-020-05720-z] [PMID: 32776162] ; (f) Azarbarzin S, Hosseinpour Feizi MA, Safaralizadeh R, et al. The Value of miR-299-5p in diagnosis and prognosis of intestinal-type gastric adenocarcinoma. Biochem Genet 2016; 54(4): 413-20.
[http://dx.doi.org/10.1007/s10528-016-9728-y] [PMID: 27007598]
[http://dx.doi.org/10.1038/onc.2013.492] [PMID: 24240682] ; (b) Hui Y, Yang Y, Li D, et al. LncRNA FEZF1-AS1 modulates cancer stem cell properties of human gastric cancer through miR- 363-3p/HMGA2. Cell Transplant 2020; 29: 963689720925059.
[http://dx.doi.org/10.1177/0963689720925059] [PMID: 32638620] ; (c) Behzadi S, Baradaran B, Hosseinpourfeizi MA, et al. BC032913 as a novel antisense non-coding RNA is downregulated in gastric cancer. J Gastrointest Cancer 2021; 53(2): 928-31.
[PMID: 32914372] ; (d) Mohammadzadeh A, Baradaran B, Dastmalchi N, Hashemzadeh S, Safaralizadeh R. The correlation between helicobacter pylori infection and lnc-oc1 expression in gastric cancer tissues in an iranian population. J Gastrointest Cancer 2021; 52(2): 600-5.
[http://dx.doi.org/10.1007/s12029-020-00438-4] [PMID: 32529394] ; (e) Azarbarzin S, Safaralizadeh R, Khojasteh MB, Baghbanzadeh A, Baradaran B. Current perspectives on the dysregulated microRNAs in gastric cancer. Mol Biol Rep 2020; 47(9): 7253-64.
[http://dx.doi.org/10.1007/s11033-020-05720-z] [PMID: 32776162] ; (f) Azarbarzin S, Hosseinpour Feizi MA, Safaralizadeh R, et al. The Value of miR-299-5p in diagnosis and prognosis of intestinal-type gastric adenocarcinoma. Biochem Genet 2016; 54(4): 413-20.
[http://dx.doi.org/10.1007/s10528-016-9728-y] [PMID: 27007598]
[10]
(a) Sun B, Han Y, Cai H, Huang H, Xuan Y. Long non-coding
RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes
stem cell-like properties of gastric cancer cells by regulating the
miR-3619-5p/ARL2 axis. Cell Oncol (Dordr) 2021; 44(1): 179-92.
[http://dx.doi.org/10.1007/s13402-020-00560-2] [PMID: 32930970] ; (b) Ruggieri V, Russi S, Zoppoli P, et al. The role of MicroRNAs in the regulation of gastric cancer stem cells: A meta-analysis of the cur-rent status. J Clin Med 2019; 8(5): E639.
[http://dx.doi.org/10.3390/jcm8050639] [PMID: 31075910]
[http://dx.doi.org/10.1007/s13402-020-00560-2] [PMID: 32930970] ; (b) Ruggieri V, Russi S, Zoppoli P, et al. The role of MicroRNAs in the regulation of gastric cancer stem cells: A meta-analysis of the cur-rent status. J Clin Med 2019; 8(5): E639.
[http://dx.doi.org/10.3390/jcm8050639] [PMID: 31075910]
[11]
Zhao M, Hou Y, Du YE, et al. Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism. Cancer Lett 2020; 478: 8-21.
[http://dx.doi.org/10.1016/j.canlet.2020.02.040] [PMID: 32142918]
[http://dx.doi.org/10.1016/j.canlet.2020.02.040] [PMID: 32142918]
[12]
Xin L, Liu L, Liu C, et al. DNA-methylation-mediated silencing of miR-7-5p promotes gastric cancer stem cell invasion via increasing Smo and Hes1. J Cell Physiol 2020; 235(3): 2643-54.
[http://dx.doi.org/10.1002/jcp.29168] [PMID: 31517391]
[http://dx.doi.org/10.1002/jcp.29168] [PMID: 31517391]
[13]
Peng C, Huang K, Liu G, Li Y, Yu C. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3. J Gastroenterol Hepatol 2019; 34(10): 1711-9.
[http://dx.doi.org/10.1111/jgh.14649] [PMID: 30843262]
[http://dx.doi.org/10.1111/jgh.14649] [PMID: 30843262]
[14]
Ji R, Zhang X, Qian H, et al. miR-374 mediates the malignant transformation of gastric cancer-associated mesenchymal stem cells in an experimental rat model. Oncol Rep 2017; 38(3): 1473-81.
[http://dx.doi.org/10.3892/or.2017.5831] [PMID: 28731132]
[http://dx.doi.org/10.3892/or.2017.5831] [PMID: 28731132]
[15]
Chen Z, Xie Y, Chen W, Li T, Chen X, Liu B. microRNA-6785-5p-loaded human umbilical cord mesenchymal stem cells-derived exo-somes suppress angiogenesis and metastasis in gastric cancer via INHBA. Life Sci 2021; 284: 119222.
[http://dx.doi.org/10.1016/j.lfs.2021.119222] [PMID: 33609542]
[http://dx.doi.org/10.1016/j.lfs.2021.119222] [PMID: 33609542]
[16]
Nishida N, Mimori K, Fabbri M, et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the prolifera-tion of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res 2011; 17(9): 2725-33.
[http://dx.doi.org/10.1158/1078-0432.CCR-10-2132] [PMID: 21220473]
[http://dx.doi.org/10.1158/1078-0432.CCR-10-2132] [PMID: 21220473]
[17]
Fan D, Ren B, Yang X, Liu J, Zhang Z. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer. J Exp Clin Cancer Res 2016; 35(1): 177.
[http://dx.doi.org/10.1186/s13046-016-0432-x] [PMID: 27846906]
[http://dx.doi.org/10.1186/s13046-016-0432-x] [PMID: 27846906]
[18]
Shao Q, Xu J, Guan X, et al. In vitro and in vivo effects of miRNA-19b/20a/92a on gastric cancer stem cells and the related mechanism. Int J Med Sci 2018; 15(1): 86-94.
[http://dx.doi.org/10.7150/ijms.21164] [PMID: 29333091]
[http://dx.doi.org/10.7150/ijms.21164] [PMID: 29333091]
[19]
Zhang L, Guo X, Zhang D, et al. Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway. Mol Carcinog 2017; 56(9): 2022-34.
[http://dx.doi.org/10.1002/mc.22656] [PMID: 28383763]
[http://dx.doi.org/10.1002/mc.22656] [PMID: 28383763]
[20]
Pan Y, Shu X, Sun L, et al. miR 196a 5p modulates gastric cancer stem cell characteristics by targeting Smad4. Int J Oncol 2017; 50(6): 1965-76.
[http://dx.doi.org/10.3892/ijo.2017.3965] [PMID: 28440445]
[http://dx.doi.org/10.3892/ijo.2017.3965] [PMID: 28440445]
[21]
Hong L, Wang H, Wang J, et al. LncRNA PTCSC3 inhibits tumor growth and cancer cell stemness in gastric cancer by interacting with lncRNA Linc-pint. Cancer Manag Res 2019; 11: 10393-9.
[http://dx.doi.org/10.2147/CMAR.S231369] [PMID: 31849528]
[http://dx.doi.org/10.2147/CMAR.S231369] [PMID: 31849528]
[22]
Sun Q, Li J, Li F, et al. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway. Cell Prolif 2019; 52(6): e12687.
[http://dx.doi.org/10.1111/cpr.12687] [PMID: 31468594]
[http://dx.doi.org/10.1111/cpr.12687] [PMID: 31468594]
[23]
Song H, Xu Y, Shi L, et al. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability. Biomed Pharmacother 2018; 108: 338-46.
[24]
Wang F, Tang C, Xu D, et al. LncRNA ADAMTS9-AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of can-cer stem cells through regulating SPOP. J Cell Mol Med 2020; 24(8): 4830-8.
[http://dx.doi.org/10.1111/jcmm.15161] [PMID: 32160650]
[http://dx.doi.org/10.1111/jcmm.15161] [PMID: 32160650]
[25]
He W, Liang B, Wang C, et al. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. Oncogene 2019; 38(23): 4637-54.
[http://dx.doi.org/10.1038/s41388-019-0747-0] [PMID: 30742067]
[http://dx.doi.org/10.1038/s41388-019-0747-0] [PMID: 30742067]
[26]
Wu H, Liu B, Chen Z, Li G, Zhang Z. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer. Cell Death Dis 2020; 11(4): 233.
[http://dx.doi.org/10.1038/s41419-020-2426-z] [PMID: 32300102]
[http://dx.doi.org/10.1038/s41419-020-2426-z] [PMID: 32300102]
[27]
Wang S, Liu F, Deng J, et al. Long noncoding RNA ROR regulates proliferation, invasion, and stemness of gastric cancer stem cell. Cell Reprogram 2016; 18(5): 319-26.
[http://dx.doi.org/10.1089/cell.2016.0001] [PMID: 27602437]
[http://dx.doi.org/10.1089/cell.2016.0001] [PMID: 27602437]
[28]
Ratti M, Lampis A, Ghidini M, et al. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: First steps from bench to bedside. Target Oncol 2020; 15(3): 261-78.
[http://dx.doi.org/10.1007/s11523-020-00717-x] [PMID: 32451752]
[http://dx.doi.org/10.1007/s11523-020-00717-x] [PMID: 32451752]
[29]
Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 2013; 12(11): 847-65.
[http://dx.doi.org/10.1038/nrd4140] [PMID: 24172333]
[http://dx.doi.org/10.1038/nrd4140] [PMID: 24172333]
[30]
Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K. The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol (Dordr) 2018; 41(6): 585-603.
[http://dx.doi.org/10.1007/s13402-018-0406-4] [PMID: 30218296]
[http://dx.doi.org/10.1007/s13402-018-0406-4] [PMID: 30218296]
[31]
Qian L, Liu F, Chu Y, et al. MicroRNA-200c nanoparticles sensitized gastric cancer cells to radiotherapy by regulating pd-l1 expression and EMT. Cancer Manag Res 2020; 12: 12215-23.
[http://dx.doi.org/10.2147/CMAR.S279978] [PMID: 33273858]
[http://dx.doi.org/10.2147/CMAR.S279978] [PMID: 33273858]
[32]
Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ, Cheng XD. Long non-coding RNAs towards precision medicine in gastric cancer: Early diagno-sis, treatment, and drug resistance. Mol Cancer 2020; 19(1): 96.
[http://dx.doi.org/10.1186/s12943-020-01219-0] [PMID: 32460771]
[http://dx.doi.org/10.1186/s12943-020-01219-0] [PMID: 32460771]
[33]
Peng X, Kang Q, Wan R, Wang Z. miR-26a/HOXC9 dysregulation promotes metastasis and stem cell-like phenotype of gastric cancer. Cell Physiol Biochem 2018; 49(4): 1659-76.
[34]
Di Martino MT, Riillo C, Scionti F, et al. miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy. Cancers (Basel) 2021; 13(7): 1587.
[http://dx.doi.org/10.3390/cancers13071587] [PMID: 33808190]
[http://dx.doi.org/10.3390/cancers13071587] [PMID: 33808190]
Article Metrics
12
1